Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to 0.65.

  • Burning Rock Biotech's Asset Utilization Ratio rose 2847.75% to 0.65 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.65, marking a year-over-year increase of 2847.75%. This contributed to the annual value of 0.53 for FY2024, which is 3131.46% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Asset Utilization Ratio of 0.65 as of Q3 2025, which was up 2847.75% from 0.64 recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Asset Utilization Ratio ranged from a high of 0.65 in Q3 2025 and a low of 0.15 during Q4 2021
  • Its 5-year average for Asset Utilization Ratio is 0.4, with a median of 0.43 in 2023.
  • Examining YoY changes over the last 5 years, Burning Rock Biotech's Asset Utilization Ratio showed a top increase of 13131.41% in 2022 and a maximum decrease of 104.21% in 2022.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Asset Utilization Ratio stood at 0.15 in 2021, then skyrocketed by 131.31% to 0.35 in 2022, then soared by 40.06% to 0.49 in 2023, then grew by 11.19% to 0.55 in 2024, then grew by 19.2% to 0.65 in 2025.
  • Its Asset Utilization Ratio stands at 0.65 for Q3 2025, versus 0.64 for Q2 2025 and 0.61 for Q1 2025.